These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4546443)

  • 1. Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor-VIII-related antigen.
    Vermylen J; De Gaetano G; Donati MB; Verstraete M
    Br J Haematol; 1974 Apr; 26(4):645-50. PubMed ID: 4546443
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor-VIII antigen and platelet retention in a glass bead column.
    Bouma BN; Sixma JJ; de Graaf S; Wiegerinck Y; van Mourik JA; Mochtar IA
    Br J Haematol; 1973 Nov; 25(5):645-56. PubMed ID: 4543139
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of anti-haemophilic factor A related antigen in haemophilia A.
    Bouma BN; van Mourik JA; Wiegerinck Y; Sixma JJ; Mochtar IA
    Scand J Haematol; 1973; 11(3):184-7. PubMed ID: 4203098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cryoprecipitates rich in factor VIII. In vitro and in vivo studies].
    Parquet-Gernez A; Bauters F
    Rev Fr Transfus; 1969 Dec; 12(4):439-50. PubMed ID: 5310871
    [No Abstract]   [Full Text] [Related]  

  • 7. A variant of factor 8 related antigen.
    Kernoff PB; Gruson R; Rizza CR
    Br J Haematol; 1974 Mar; 26(3):435-40. PubMed ID: 4211768
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Autosomal haemophilia': a variant of von Willebrand's disease.
    Veltkamp JJ; van Tilburg NH
    Br J Haematol; 1974 Jan; 26(1):141-52. PubMed ID: 4546581
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase.
    Levy-Toledano S; Caen JP; Halmos T; Mester L
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:60-2. PubMed ID: 4587019
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a qualitative defect in factor-VIII-related antigen in von Willebrand's disease.
    Thomson C; Forbes CD; Prentice CR
    Lancet; 1974 Apr; 1(7858):594-6. PubMed ID: 4132261
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity.
    Baugh R; Brown J; Sargeant R; Hougie C
    Biochim Biophys Acta; 1974 Dec; 371(2):360-7. PubMed ID: 4433572
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Von Willebrand factor and factor-viii-related antigen.
    Stableforth P; Barrowcliffe TW; Dormandy K
    Lancet; 1974 Apr; 1(7859):685. PubMed ID: 4132355
    [No Abstract]   [Full Text] [Related]  

  • 15. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
    Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 19. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: 8-related antigen and von Willebrand factor.
    Firkin B; Koutts J
    Lancet; 1974 Apr; 1(7861):803-4. PubMed ID: 4132731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.